Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of DL-3-n-butylphthalide on Chemotherapy-Induced Cognitive Impairment (NBP CICI)：a Prospective, Randomized, Double Blinded, Multicenter, Placebo Controlled Study

NCT06508671 is registered in ClinicalTrials.gov with First Hospital of China Medical University as lead sponsor.

NCT NCT06508671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06508671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of DL-3-n-butylphthalide on Chemotherapy-Induced Cognitive Impairment (NBP CICI)：a Prospective, Randomized, Double Blinded, Multicenter, Placebo Controlled Study
Lead sponsor
First Hospital of China Medical University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
July 31, 2024
Completion date
December 31, 2026
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-related cognitive impairment, dl-3-n-butylphthalide